跳至主要内容
临床试验/IRCT20230408057842N2
IRCT20230408057842N2招募中3 期

Exploring Intragastric Botulinum Toxin Injections: A Prospective study on the rate of Weight Loss in Overweight and Obese Patients

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Body mass index (BMI) between 25-39.9 kg/m^2
  • Willingness to participate in the intervention
  • Absence of any other comorbidity
  • Absence of any contraindications for botulinum toxin administration

排除标准

  • Participants with a history of previous bariatric surgery
  • BMI=40 kg/m^2
  • Known allergy to any ingredients in Masport or allergic reaction
  • Pregnancy or lactation
  • Known pre-existing neuromuscular disorders or peripheral motor neuropathic disease (e.g. amyotrophic lateral sclerosis, motor neuropathy)
  • Patients with known liver cirrhosis or known esophageal/gastric varices
  • Known eating disorders
  • Known major cardiovascular or pulmonary conditions
  • Pathologic changes of the esophagus/stomach/duodenum demonstrated on endoscopy (esophagitis, peptic ulcers, cancer)
  • Known alcohol or drug abuse

研究者

相似试验